06/07/2026
Sleep problems are one of the most common — and most undertreated — symptoms of menopause.
THE PROBLEM
Sleep disturbance affects 40–69% of women during the menopause transition, with up to 40% meeting criteria for insomnia disorder. Two mechanisms are at play — and they're independent of each other:
Night sweats fragment sleep. Women with moderate-to-severe VMS are almost 3x more likely to report frequent nocturnal awakenings.
Hormone decline directly affects sleep architecture. Even after accounting for VMS and depression, lower estradiol and higher FSH are independently associated with more nighttime awakenings. Progesterone loss removes a natural sleep-promoting neurosteroid.
SWAN data showed women with persistent insomnia over midlife had a 71% increased risk of cardiovascular events — rising to 75% with concurrent short sleep. Poor sleep is also linked to insulin resistance, obesity, and cognitive decline.
CBT for Insomnia (CBT-I) — First-line treatment. An RCT of 150 postmenopausal women showed remission rates of 54–84%. Can be delivered by phone, online, or in groups.
Hormone Therapy — A meta-analysis of 15 RCTs found HT improved sleep quality, with transdermal estradiol showing the largest effect. Estrogen + progesterone outperformed estrogen alone.
Micronized Progesterone — Acts through GABA-A receptor modulation. One RCT showed it reduced wake-after-sleep-onset by 53% and increased deep sleep by nearly 50% — without the EEG distortions of traditional hypnotics.
Exercise — Both low- and moderate-intensity exercise significantly improved sleep in menopausal women.
You don't have to just live with it. If you're ready for help, reach out today. I can help.
clarityphysicianpartners.com/drjac
Cognitive Behavioural Therapeutics for Insomnia Symptoms in the Perimenopause Through to the Early Postmenopausal Period. Cochrane Database of Systematic Reviews. 2026.
Disruption of Sleep Continuity During the Perimenopause. Journal of Clinical Endocrinology and Metabolism. 2022.